Caged HIV-1 protease: Dimerization is independent of the ionization state of the active site aspartates

Journal of the American Chemical Society

Volumn 121, Issue 2, 1999, Pages 478-479

  Short III, Glenn F ^a   Lodder, Michiel ^a   Laikhter, Andrei L ^a   Arslan, Tuncer ^a   Hecht, Sidney M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTIC ACID; PROTEINASE;

ARTICLE; AUTORADIOGRAPHY; CATALYSIS; CROSS LINKING; DIMERIZATION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; HUMAN IMMUNODEFICIENCY VIRUS 1; HYDROGEN BOND; IONIZATION; PROTEIN DEGRADATION; REACTION ANALYSIS; STRUCTURE ANALYSIS;

EID: 0033585614     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja9838054     Document Type: Article

References (45)

1. Debouck, C. AIDS Res. Hum. Retroviruses 1992, 8, 153.
2. Kohl, N. E.; Emini, E. A.; Schleif, W. A.; Davis, L. J.; Heimbach, J. C.; Dixon, R. A.; Scolnick, E. M.; Sigal, I. S. Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 4686.
3. For a review on HIV-1 protease inhibitors currently used for the treatment of AIDS, see: Vacca, J. P. Drug Discovery Today 1997, 7, 261.
4. (a) Pearl, L. H.; Taylor, W. R. Nature 1987, 329, 351.
5. (b) Meek, T. D.; Dayton, B. D.; Metcalf, B. W.; Dreyer, G. B.; Strickler, J. E.; Gorniak, J. G.; Rosenberg, M.; Moore, M. L.; Magaard, V. W.; Debouck, C. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 1841.
6. (c) Wlodawer, A.; Miller, M.; Jaskolski, M.; Sathyanarayana, B. K.; Baldwin, E.; Weber, I. T.; Selk, L. M.; Clawson, L.; Schneider, J.; Kent, S. B. H. Science 1989, 245, 616.
7. (a) Hyland, L. J.; Tomaszek, T. A., Jr.; Roberts, G. D.; Carr, S. A.; Magaard, V. W.; Bryan, H. L.; Fakhoury, S. A.; Moore, M. L.; Minnich, M. D.; Culp, J. S.; DesJarlais, R. L.; Meek, T. D. Biochemistry 1991, 30, 8441.
8. (b) Hyland, L. J.; Tomaszek, T. A., Jr.; Meek, T. D. Biochemistry 1991, 30, 8454.
9. (c) Ido, E.; Han, H.; Kezdy, F. J.; Tang, J. J. Biol. Chem. 1991, 36, 24359.
10. (d) Meek, T. D.; Rodriguez, E. J.; Angeles, T. S. Methods Enzymol. 1994, 241, 127.
11. Smith, R.; Brereton, I. M.; Chai, R. Y.; Kent, S. B. H. Nature Struct. Biol. 1996, 3, 946.
12. 8 have demonstrated that a mutant protease containing Asn25 could form a dimer, albeit of lesser stability.
13. (a) Dilanni, C. L.; Darke, P. L.; Dixon, R. A. F.; Sigal, I. S. Current Research in Protein Chemistry: Techniques, Structure, and Function; Academic Press; Orlando, 1990; pp 521-528.
14. (b) Dilanni, C. L.; Davis, L. J.; Holloway, K.; Herber, W. K.; Darke, P. L.; Kohl, N. E.; Dixon, R. A. F. J. Biol. Chem. 1990, 265, 17348.
15. (a) Noren, C. J.; Anthony-Cahill, S. J.; Griffith, M. C.; Schultz, P. G. Science 1989, 244, 182.
16. (b) Ellman, J.; Mendel, D.; Anthony-Cahill, S.; Noren, C. J.; Schultz, P. G. Methods Enzymol. 1991, 202, 301.
17. (c) Bain, J. D.; Wacker, D. A.; Kuo, E. E.; Chamberlin, A. R. Tetrahedron 1991, 47, 2389.
18. (d) Bain, J. D.; Diala, E. S.; Glabe, C. G.; Wacker, D. A.; Lyttle, M. H.; Dix, T. A.; Chamberlin, A. R. Biochemistry 1991, 30, 5411.
19. (e) Bain, J. D.; Switzer, C., Benner, S. A.; Chamberlin, A. R. Nature 1992, 356, 537.
20. (f) Cornish, V. W.; Mendel, D.; Schultz, P. G. Angew. Chem., Int. Ed. Engl. 1995, 34, 621.
21. (g) Mamaev, S. V.; Laikhter, A. L.; Arslan, T.; Hecht, S. M. J. Am. Chem. Soc. 1996, 118, 7243.
22. (h) Karginov, V A.; Mamaev, S. V.; An, H.; Van Cleve, M. D.; Hecht, S. M.; Komatsoulis, G. A.; Abelson, J. N. J. Am. Chem. Soc. 1997, 119, 8166.
23. (i) Karginov, V. A.; Mamaev, S. V.; Hecht, S. M. Nucleic Acids Res. 1997, 25, 3912.
24. (j) Arslan, T.; Mamaev, S. V.; Mamaeva, N. V.; Hecht, S. M. J. Am. Chem. Soc. 1997, 119, 10877.
25. (k) Killian, J. A.; Van Cleve, M. D.; Shayo, Y. F.; Hecht, S. M. J. Am. Chem. Soc. 1998, 120, 3032.
26. (a) Hecht, S. M.; Alford, B. L.; Kuroda, Y.; Kitano, S. J. Biol. Chem. 1978, 253, 4517.
27. (b) Baldini, G.; Martoglio, B.; Schachenmann, A.; Zugliani, C.; Brunner, J. Biochemistry 1988, 27, 7951.
28. (c) Bain, J. D.; Glabe, C. G.; Dix, T. A.; Chamberlin, A. R.; Diala, E. S. J. Am. Chem. Soc. 1989, 111, 8013.
29. (d) Roesser, J. R.; Xu, C.; Payne, R. C.; Surratt, C. K.; Hecht, S. M. Biochemistry 1989, 28, 5185.
30. (e) Robertson, S. A.; Noren, C. J.; Anthony-Cahill, S. J.; Griffith, M. C.; Schultz, P. G. Nucleic Acids Res. 1989, 17, 9649.
31. (f) Robertson, S. A.; Ellman, J. A.; Schultz, P. G. J. Am. Chem. Soc. 1991, 113, 2722.
32. (g) Hecht, S. M. Acc. Chem. Res. 1992, 25, 545.
33. (h) Lodder, M.; Golovine, S.; Hecht, S. M. J. Org. Chem. 1997, 62, 778.
34. (a) For a review on caged compounds, see: Adams, S. R.; Tsien, R. Y. Annu. Rev. Physiol 1993, 55, 755.
35. (b) Mendel, D.; Ellman, J. A.; Schultz, P. G. J. Am. Chem. Soc. 1991, 113, 2758.
36. 8 All constructs encoded a hexahistidine fusion peptide.
37. Restoration of proteolytic activity was possible after purification of the monomer by nickel affinity chromatography, followed by dialysis.
38. (a) Matayoshi, E. D.; Wang, G. T.; Krafft, G. A.; Erickson, J. Science 1990, 247, 954.
39. 8b (a) Loeb, D. D.; Swanstrom, R.; Everitt, L.; Manchester, M.; Stamper, S. E.; Hutchison, C. A., III Nature 1989, 340, 397. (b) Krausslich, H.-G. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 3213. The minimal (13%) activity measured for the dimeric protease containing 5 at position 25 is attributed to adventitious solvolysis during protein sample preparation.
40. 8b (a) Loeb, D. D.; Swanstrom, R.; Everitt, L.; Manchester, M.; Stamper, S. E.; Hutchison, C. A., III Nature 1989, 340, 397. (b) Krausslich, H.-G. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 3213. The minimal (13%) activity measured for the dimeric protease containing 5 at position 25 is attributed to adventitious solvolysis during protein sample preparation.
41. For a review of water-soluble palladium catalysts, see: Herrmann. W. A.; Kohlpaintner, C. W. Angew. Chem., Int. Ed. Engl. 1993, 32, 1524.
42. Under denaturing conditions, in the presence of 6 M urea and 2 mM catalyst, Pd-catalyzed deblocking afforded an active protease monomer having a specific activity 85% that of wild type (16 h incubation. 23°C). whereas the caged enzyme was inactive (Supporting Information. Figure 3).
43. It may be possible to employ this protecting group under native conditions using wcll-solvated aspartates on the surface of enzymes. See: Pollit, S. K.; Schultz, P. G. Angew. Chem., Int. Ed. Engl. 1998, 37, 2104.
44. That the formed dimer had a structure fundamentally analogous to that of the native enzyme can be appreciated by the full restoration of enzymic activity following irradiation of the caged dimer (Figure 2).
45. Mildner, A. M.; Rothrock, D. J.; Leone, J. W.; Bannow, C. A.; Lull, J. M.; Reardon, I. M.; Sarcich, J. L.; Howe, W. J.; Tomich, C.-S. C.; Smith, C. W.; Heinrikson, R. L.; Tomasselli, A. G. Biochemistry 1994, 33, 9405.